• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Systematic approach for severe respiratory failure due to novel A (H1N1) influenza

tetano

Editor, Senior Moderator
Minerva Anestesiol. 2011 May;77(5):510-21.
Systematic approach for severe respiratory failure due to novel A (H1N1) influenza.
Cornejo R, Tobar E, D?az G, Romero C, Llanos O, G?lvez LR, Zamorano A, F?brega L, Neira W, Arellano D, Repetto C, Aedo D, Carlos D?az J, Gonz?lez R.
Source

Intensive Care Unit, Department of Medicine, Hospital Cl?nico Universidad de Chile. Santiago, Chile - racornej@gmail.com.
Abstract
AIM:

In April 2009, a novel influenza A (H1N1) virus appeared in Mexico. It rapidly acquired the characteristics of a pandemic disease. Our objective is to present a case series of mechanically ventilated patients with severe influenza, treated with a systematic approach.
METHODS:

Prospective, observational, single-center study in a University Hospital. A (H1N1) virus was confirmed by rRT-PCR. In this report, we only considered patients that required mechanical ventilation (MV). All patients received antibiotics, steroids and oseltamivir from the time of admission. The main strategies incorporated in the systematic approach were a lung-protective strategy, PEEP adjusted for each patient, protocol-guided sedoanalgesia, restrictive fluid management, weaning protocol, and prolonged prone ventilation and extracorporeal membrane oxygenation (ECMO) as rescue therapies.
RESULTS:

We studied 19 patients: age 41?13 years old, APACHE II 16?7 and SOFA 8?4. All patients presented PaO2/FiO2≤200 before connection to MV. Their worst values within the first 24 hours for oxygenation index, PaO2/FiO2, and PaCO2 on MV were 21.8?13, 98?39, and 48?16 mmHg, respectively. Sixteen patients achieved ARDS; three exhibited acute lung injury criteria. Ten required a prone position, and two required ECMO (one patient required both therapies). Time on MV was 16?13 days. Length of stay in the ICU and in hospital was 18?12 and 28?17 days, respectively. Mortality was 21%.
CONCLUSION:

Severe hypoxemia and a high rate of rescue therapies were observed among our patients. Nevertheless, mortality was lower than previously reported in comparable populations, which may be related to the management by a critical care team and the use of a systematic approach for ventilatory and non-ventilatory therapeutic strategies.

PMID:
21540806
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/21540806
 
Back
Top Bottom